Our data showed a trend for preservation of menstrual bleeding in patients receiving goserelin treatment concurrently with chemotherapy, but the difference was not statistically significant (Table 2 ).
← all excerpts
SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.
1
—
—